Tag Archives: social media
Do You Have a Head of Social Media?
And do you need one? Julian Upton looks at some of the contrasting ideas that emerged from last month’s Digital Pharma Europe event.
If anyone had any lingering doubts about an unprecedented era of inclusion and transparency promised by pharma’s newfound, if tentative, embrace of online social media, then last month’s Digital Pharma Europe conference must [...]
Posted in E-Media, Europe, Events, Guest Blog, Strategy, Technology Also tagged corporate comminications, digital, Internet, online strategy, patient communications 1 Comment
PhRMA Calls for New Style Search Link Ads
The Pharmaceutical Research and Manufacturers of America (PhRMA), on Tuesday, revealed its comments to FDA about how to handle search link ads on sites such as Google and Yahoo.
PhRMA showed off two versions of its recommended search ad, one with a universal symbol that’s easily recognizable as a link to risk information (the sample one [...]
Tweeting to Your Facebook: Why Pharma Is So Bad With Social Media
For those of you who didn’t know, it’s Social Media Week. Granted, the week is almost over, but the panel that you all care about didn’t take place until yesterday afternoon here in NYC.
The panel’s mouthful of a name—“Navigating Social Media & New Technology in Healthcare & Pharmaceutical Industries”—is nevertheless an accurate description of the [...]
Posted in E-Media, Marketing Also tagged adverse events, DJ Edgerton, Facebook, Jay Parkinson, Lipitor, Marketing, Saatchi, Twitter, Zemoga 5 Comments
AZ’s First Corporate Blog Falls Flat
Currently, if patients or doctors look for specific drug information on AZ Health Connections, AstraZeneca’s new corporate communications blog, they won’t find any. And that’s exactly how AZ—along with pretty much every other pharma company engaged in the social media sphere—wants it.
“The one area we’re trying not to engage is specific questions about disease state,” [...]
Posted in E-Media Also tagged AstraZeneca, Community, Company, Food and Drug Administration, Health care, Virtual community, Washington DC 3 Comments

Patients Want to Talk. Do You?